The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 33

More JCP Articles

JCP
Abbreviated Suicide Crisis Syndrome Checklist and Decision Making in the ED
Original Research

May 1, 2023

The A-SCS-C had robust clinical utility and reduced clinicians’ reliance on patient-reported suicidal ideation to assess suicide risk in the ED setting.
, , , et al
JCP
rTMS for Treatment-Resistant Depression: Mismatch of Evidence and Insurance Coverage Policies
Commentary

April 26, 2023

The authors argue that insurance companies’ prior authorization process overly restricts access to rTMS, which has proven effectiveness for TRD.
, , , et al
JCP
Efficacy of Lumateperone in Bipolar Depression With Mixed Features
Original Research

April 24, 2023

Lumateperone significantly improved depression symptoms, disease severity, and quality of life in patients with bipolar depression with mixed features.
, , , et al
JCP
Pregnancy-Specific Anxiety Tool: Development and Psychometric Evaluation
Original Research

image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ April 19, 2023

The Pregnancy-Specific Anxiety Tool contributes new dimensions to the measurement of anxiety in pregnancy. Patients scoring higher than 10 on the PSAT require further assessment.
, , , et al
JCP
LAI Implementation After Schizophrenia Diagnosis
Original Research

April 19, 2023

Although long-acting injectable antipsychotic agents (LAIs) are effective in preventing relapse, their use in first-episode schizophrenia was low, and LAIs were rarely the first therapy for early-phase schizophrenia.
, , , et al
JCP
Depression and Cue Reactivity in Opioid Use Disorder Patients Receiving Extended-Release Naltrexone
Brief Report

April 17, 2023

Greater depression severity was linked to less reduction in cue-induced craving during naltrexone treatment for OUD.
, , , et al
JCP
Pandemics and Suicide Rates in Spain: From the Spanish Flu to COVID-19
Original Research

April 17, 2023

Deaths by suicide peaked in Spain during both the Spanish flu and COVID-19 pandemics; however, the stressors that led to these increases differed based on historical context.
, , , et al
JCP
Interpersonal Trauma and Depression Severity in Bipolar Disorder
Original Research

April 10, 2023

In bipolar disorder patients currently receiving treatment, a history of childhood trauma was associated with more severe depression.
, , , et al
JCP
Pharmacotherapy and Ketamine Assisted Psychotherapy for Treatment-Resistant Depression
Cross Talk: Case Conferences From MGH

April 5, 2023

A 61-year-old patient with TRD and a history of self-criticism sought ketamine assisted psychotherapy. Experts from diverse therapeutic perspectives discuss this intriguing case.
, , , et al
JCP
Enhanced Primary Care for People With Serious Mental Illness
Original Research

April 5, 2023

Primary care adapted to the needs of people with SMI improved hemoglobin A1c and systolic blood pressure when compared to usual care.
, , , et al
JCP
Gestational Exposure to Benzodiazepines and Z-Hypnotics and Risk of Adverse Pregnancy Outcomes
Clinical and Practical Psychopharmacology

April 3, 2023

Chittaranjan Andrade, MD, discusses recent studies on exposure to benzodiazepines and hypnotics and risk of major congenital malformation and other adverse pregnancy outcomes.
JCP
Impact of Tardive Dyskinesia on Patient Lives
Original Research

April 3, 2023

This survey reveals the substantial burden of tardive dyskinesia on people’s lives and on the management of their underlying condition.
, , , et al

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Read the full report
Figure shows a syringe and vials with title on aripiprazole monohydrate LAI use in schizophrenia and a red READ NOW button.

Subscribe to read
more articles

Subscribe